Stay updated on BBI608 Combo with Immune Checkpoint Inhibitors Clinical Trial
Sign up to get notified when there's something new on the BBI608 Combo with Immune Checkpoint Inhibitors Clinical Trial page.

Latest updates to the BBI608 Combo with Immune Checkpoint Inhibitors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe clinical trial record for BBI608 combined with immune checkpoint inhibitors is now displayed, with details on the study design, participating locations, eligibility, interventions, and outcome measures.SummaryDifference51%

- Check20 days agoChange DetectedThe ClinicalTrials.gov footer shows an updated site revision number, from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check27 days agoChange DetectedA site-wide NIH notice announces updates and FAQs about using “Super Intelligence” in place of “Artificial Intelligence” during a terminology transition.SummaryDifference1%

- Check34 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check41 days agoChange DetectedThe revision label in the footer changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page now displays a 403 Forbidden error page with the site header and footer, replacing the expected study record content. This indicates the page is inaccessible or access is restricted.SummaryDifference18%

Stay in the know with updates to BBI608 Combo with Immune Checkpoint Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BBI608 Combo with Immune Checkpoint Inhibitors Clinical Trial page.